Dublin, Oct. 19, 2017 -- The "Global DEXA Equipment Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.
In this region, global DEXA Equipment Market is projected to reach USD 370.3 million by 2024 from USD 213.8 million in 2016, at a CAGR of 7.1% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are rising prevalence of chronic diseases, fast growing incidence of hip and vertebral fractures, quick and accurate detection, technological advancements, and growing geriatric population.
Scope of the Report
- On the basis of product type, the global DEXA equipment market is segmented into central DEXA (C-DEXA) and peripheral DEXA (p-DEXA).
- On the basis of application, the global DEXA equipment market segment is segmented into bone densitometry, body composition analysis, fracture risk assessment and fracture diagnosis. In 2017, bone densitometry segment is expected to dominate the global DEXA equipment market segment.
- On the basis of end user, the global DEXA equipment market segment is segmented into hospitals, clinics, and mobile health centers.
Market Dynamics
Drivers
- Rising Incidence of Chronic Diseases
- Quick and Accurate Detection
- Technological Advancements
- Growing Geriatric Population
Restraints
- Risk to Pregnant Women
- Regulatory Framework
- Lack of Trained Staff
Opportunities
- Growing Medical Tourism in Asia
Challenges
- Exposure to Radiation
- Pitfalls in Measuremen
- Difficult in Interpretation of Dexa Results
Hologic, Inc. is going to dominate the DEXA equipment market following with followed by GE Healthcare and Osteometer Meditech Inc., along with others such as Swissray International, Inc.
All Companies Featured
- Ampall Co. Ltd
- BM Tech
- Demetech AB
- DMS Imaging
- GE Healthcare
- Hologic Inc.
- L'Acn S.R.L
- MB Tech
- Medilink
- Osteometer Meditech Inc, ( a Subsidiary of OSI Systems Inc)
- Swissray International Inc
- The ACN Srl
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global Dexa Equipment Market, by Type
7. Global Dexa Equipment Market, by Application
8. Global Dexa Equipment Market, by End User
9. Global Dexa Equipment Market, by Geography
10. Global Dexa Equipment Market, Company Share
11. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/25pwp2/global_dexa
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Radiography


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 



